To determine whether the therapeutic effects provided by LX/IL-24-modified tumor cell immunization were tumor specific, melanoma-bearing mice were also treated with irradiated EL-4 cells or irradiated EL-4 cells modified with LX/IL-24 (Figure 5C). The gene discussed is IL24; the disease is melanoma.